Study of the Effect of Statin Therapy on the Serum Co-enzyme Q10 levels in Patients taking Statins

Director0 个研究点目标入组 100 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•EXCLUSION CRITERIA FOR STATIN GROUP:
•1.Patients with diagnosed myopathy before the start of statin therapy or other cause of myopathy
•2.Patients with co-existing diabetes or other diagnosed causes of peripheral neuropathy (diabetes, renal insufficiency, use of alcohol, hypothyroidism, cancer, AIDS, connective tissue disorder, heavy metal intoxication, cobalamine and folate deficiency).
•3.Patients with reported hearing loss (conductive or sensorineural) before the start of statin therapy
•4.Patients who have contraindications for NCT (Pacemakers).
•5.Patients taking the following drugs: chemotherapy, gold, phenytoin, amiodarone, isoniazid, ethambutol, metronidazole, nitrofurantoin, chloramphenicol, griseofulvin, disulfiram, dapsone, cimetidine, colchicine, hydralazine, pyridoxine, thalidomide.
•EXCLUSION CRITERIA FOR NORMAL HEALTHY VOLUNTEERS:
•1.Diabetes
•2.Muscular Dystrophies
•3.Parkinsonâ??s Disease
•4.Patients taking statins, antidiabetic drugs, anti-depressants, chemotherapeutic drugs

发起方

Director